The disappointing results of the large, randomised controlled trials showing no benefit of vaccines in patients with advanced and metastatic melanoma call for a reassessment of the development of therapeutic vaccines and the importance of better immune monitoring methodology, such as adoptive T-cell therapy with lymphodepletion.
Related Articles
Senza categoria
N E W S R O U N D
Cutting Edge
The vitamin D question: what’s the best advice?
Impact Factor
Leave a Reply